MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from labcorp
sale
$197,770K
Proceeds from sale of
investments
$52,182K
Proceeds from the sale of
property, plant and...
$287K
Net cash provided by
(used in) investing...
$230,296K
Effect of exchange rate
changes on cash, cash...
$3,429K
Canceled cashflow
$19,943K
Net (decrease)
increase in cash, cash...
-$62,873K
Canceled cashflow
$233,725K
Depreciation and
amortization
$91,627K
Non-cash interest
$66,257K
Inducement expense and loss
on debt conversion
$32,647K
Accounts receivable, net
-$30,213K
Equity-based compensation
employees and...
$10,714K
Amortization of deferred
financing costs
$5,234K
Impairment charges
$1,007K
Change in fair value of
equity securities and...
-$623K
Foreign currency
measurement
$178K
Losses from
investments in investees
-$29K
Other assets
-$23K
Borrowings on lines of
credit
$33,033K
Capital expenditures
$12,278K
Investments in investees
$7,665K
Net cash used in
operating activities
-$178,542K
Canceled cashflow
$238,552K
Net cash (used in)
provided by financing...
-$118,056K
Canceled cashflow
$33,033K
Net income (loss)
-$225,680K
Gain on sale of assets
$101,576K
Accrued expenses and
other liabilities
-$47,839K
Deferred income tax
provision
-$14,999K
Accounts payable
-$14,217K
Other current assets
and prepaid...
$5,420K
Inventory, net
$4,118K
Realized loss (gain) on
disposal of fixed assets...
$3,245K
Repurchase of 2029
convertible notes
$62,208K
Share repurchase
$47,040K
Repayments of lines of
credit
$41,411K
Net activity from
the exercise of...
-$256K
Settlement of convertible
notes
$174K
Back
Back
Cash Flow
source: myfinsight.com
OPKO HEALTH, INC. (OPK)
OPKO HEALTH, INC. (OPK)